CASE DISCUSSION

Alpha Lipoic Acid in Oxidative Stress

Presented from India by Dr. Hasan Husein Hasan Moshtohry

Likes

892045

Views

35,682

40,142

Bookmarks

Case Description

Alpha-lipoic acid (ALA) is a potent antioxidant that helps combat oxidative stress by neutralizing free radicals. It regenerates other antioxidants like vitamin C and E, enhancing overall antioxidant defense. ALA plays a crucial role in reducing cellular damage caused by conditions like diabetes,...

Case Summary

Alpha-lipoic acid (ALA), or thioctic acid, is a naturally occurring organophosphorus compound vital for enzymatic function within mitochondria. It exists in two optical isomers, R and S, with the R form being naturally present and the S form chemically prepared. ALA is amphiphilic, enabling its action both within cell membranes and cytoplasm. Food sources of ALA include spinach, kidney, heart, liver, and broccoli.

Speaker Profile

Dr. Hasan Husein Hasan Moshtohry

Consultant Internal Medicine, Mediclinic Al Noor Hospital, Abu Dhabi, UAE

Dr. Hasan Husein Hasan Moshtohry, an accomplished Consultant in Internal Medicine, holds an extensive academic and professional background. With qualifications including FRCP Edin (2024), MRCP UK (2012), EDIC (2011), and a Master’s in Internal Medicine (2001), he has served in leading roles across the UAE and Egypt. Currently at Mediclinic Al Noor Hospital since 2020, his previous positions include roles at Mafraq and Rashid hospitals, where he contributed significantly to critical care and internal medicine. Dr. Hasan has been a program director, examiner, and active contributor to scholarly work, with numerous publications, conference presentations, and awards, such as the Rashid Hospital Academic Award (2011). His expertise spans hyperlipidemia, diabetes management, cardiovascular health, and antibiotic stewardship, underlining his dedication to advancing medical education and patient care.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.